- Report
- May 2026
- 150 Pages
Global
From €2512EUR$2,699USD£2,101GBP
- Report
- May 2026
- 150 Pages
Global
From €2512EUR$2,699USD£2,101GBP
- Report
- July 2026
- 283 Pages
Global
From €7436EUR$7,990USD£6,219GBP
- Report
- September 2026
- 140 Pages
Global
From €4421EUR$4,750USD£3,697GBP
- Report
- August 2026
- 112 Pages
Global
From €4421EUR$4,750USD£3,697GBP
- Report
- January 2026
- 120 Pages
Global
From €4421EUR$4,750USD£3,697GBP
- Report
- August 2026
- 160 Pages
Global
From €3090EUR$3,320USD£2,584GBP
€3862EUR$4,150USD£3,230GBP
- Report
- August 2026
- 160 Pages
Global
From €3090EUR$3,320USD£2,584GBP
€3862EUR$4,150USD£3,230GBP
- Report
- April 2026
- 91 Pages
Global
From €3500EUR$4,028USD£3,030GBP
- Report
- April 2026
- 99 Pages
Global
From €3500EUR$4,028USD£3,030GBP
- Report
- February 2026
- 96 Pages
Global
From €3500EUR$4,028USD£3,030GBP
- Report
- March 2026
- 209 Pages
Global
From €4607EUR$4,950USD£3,853GBP
- Report
- October 2025
- 96 Pages
Global
From €4188EUR$4,500USD£3,503GBP
- Report
- March 2026
- 286 Pages
United States
From €4514EUR$4,850USD£3,775GBP
- Report
- March 2026
- 107 Pages
Asia Pacific
From €3676EUR$3,950USD£3,074GBP
- Report
- March 2026
- 104 Pages
Europe
From €3676EUR$3,950USD£3,074GBP
- Report
- March 2026
- 80 Pages
Africa, Middle East
From €3211EUR$3,450USD£2,685GBP
- Report
- March 2026
- 88 Pages
North America
From €3211EUR$3,450USD£2,685GBP
- Report
- October 2026
Global
From €450EUR$518USD£390GBP
- Report
- March 2025
- 84 Pages
Global
From €400EUR$460USD£346GBP

Interleukins are a group of cytokines, or proteins, that are involved in the regulation of the immune system. They are produced by a variety of cells, including T cells, B cells, and macrophages, and are involved in a wide range of biological processes, including inflammation, cell growth, and differentiation. Genomics has enabled researchers to better understand the role of interleukins in the immune system, and to develop new therapies for a variety of diseases.
In recent years, the interleukin market has grown significantly, with a number of companies developing new therapies and diagnostic tests. Companies such as AbbVie, Amgen, and Novartis are developing new interleukin-based therapies for a variety of diseases, while companies such as Genentech and Merck are developing diagnostic tests to detect interleukin levels in patients. Additionally, a number of biotechnology companies are developing new interleukin-based therapies for a variety of diseases. Show Less Read more